BioVentrix Inc.

BioVentrix Inc. specializes in temporary cardiac assist devices. Their primary product, the Revivent TC, is designed to provide short-term mechanical circulatory support for patients experiencing acute heart failure. This device helps improve heart function by increasing cardiac output and reducing symptoms during critical periods.

BioVentrix Inc. is based in the United States. Since their device, the Revivent TC, is classified as a Class III medical device, it is subject to stringent regulatory requirements in regions like the EU, where it is listed in the eudamed database. Class III classification typically means the device supports or sustains human life, is of substantial importance in preventing impairment, or presents a potential unreasonable risk of illness or injury. This classification requires rigorous evaluation and compliance with regulatory standards.

BioVentrix Inc.’s Revivent TC device is listed in the EU’s eudamed database. This registry is important because it serves as an official record of medical devices authorized for placement on the European market. Listing in eudamed ensures transparency and traceability, allowing healthcare professionals, regulators, and patients to verify the device’s compliance with EU regulations and its authorized status for use.

BioVentrix Inc.’s Revivent TC is classified as a Class III medical device. This classification is the highest risk category under EU regulations and applies to devices that either support or sustain life, are implanted, or present a significant risk if they fail. Due to its critical role in providing temporary cardiac support, the Revivent TC requires comprehensive clinical evidence, rigorous manufacturing controls, and post-market surveillance to ensure safety and effectiveness.